# OnCo record checkmate-816 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/checkmate-816/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "checkmate-816", "NCT02998528" ;
  schema:name "CheckMate 816"@en ;
  schema:description "CheckMate 816 was the first trial to show that immunotherapy before lung cancer surgery improves survival."@en ;
  schema:url <https://onco.cc/trials/checkmate-816/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02998528> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-03-04" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/pcr/> ;
  onco:people <https://onco.cc/people/tina-cascone/>, <https://onco.cc/people/jonathan-spicer/>, <https://onco.cc/people/valerie-rusch/>, <https://onco.cc/people/patrick-forde/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-816-nejm-2022/>, <https://onco.cc/key-papers/paper-checkmate-816-n-engl-j-med-2025-update/> .